Skip to content

Dosimetric study of CT-guided post-mounted intracavitary combined with interstitial tissue insertion radiotherapy for cervical cancer

Dosimetric study of CT-guided post-mounted intracavitary combined with interstitial tissue insertion radiotherapy for cervical cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043508
Enrollment
Unknown
Registered
2021-02-21
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer

Interventions

Group A:receive interstitial brachytherapy based on three tubes
Group B:receive intracavitary combined free brachytherapy

Sponsors

Department of oncology, Affiliated Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Patients with cervical adenocarcinoma, squamous cell carcinoma or adenosquamous cell carcinoma, stage ib-iv; 2. The newly treated patients were treated with radical radiotherapy in the Department of oncology, Affiliated Hospital of Southwest Medical University. After the external irradiation, the residual tumor was larger than or equal to 4cm in diameter, eccentric lesions, parametrial involvement and acceptable vaginal elasticity; 3. Patients without IUD and serious cardiovascular and cerebrovascular complications had blood routine parameters of platelets above 75 * 10 ^ 9 / L, neutrophils above 1.5 * 10 ^ 9 / L, no severe anemia and coagulation dysfunction; 4. Patients who agreed to participate in the study and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications to radiotherapy; 2. Patients who are unable to be admitted into the uterine cavity, pregnant women, AIDS patients, and serious medical complications. 3. Subjects without informed consent; 4. Other conditions not suitable for inclusion.

Design outcomes

Primary

MeasureTime frame
Conformity of target area;Target coverage;

Countries

China

Contacts

Public ContactLi Dan

Department of oncology, Affiliated Hospital of Southwest Medical University

lidan0918@163.com+86 15884169140

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026